FindTrial
Sign In

Shanghai CML Registry Study

Shanghai CML Registry Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023929
Enrollment
Unknown
Registered
2019-06-18
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic myeloid leukemia

Interventions

Case series:None

Sponsors

Shanghai Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. diagnosed with Ph+ or BCR-ABL+ CML in any phases of the disease; 2. patient is over the age of 16 years; 3. Has provided informed consent.

Exclusion criteria

Exclusion criteria: Any patient, in the physician's opinion, has something ineligible for the purpose of the registry.

Design outcomes

Primary

MeasureTime frame
OS;—

Secondary

MeasureTime frame
PFS;EFS;MMR;DMR;Cytogenetic response;hematological response;—

Countries

China

Contacts

Public ContactZhou Li

Shanghai Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine

lizhou999_999@126.com+86 13816510379

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026